| Blog results | Results 1 - 10 of about 17,593 for san antonio breast cancer conference. (0.20 seconds) |
| Sorted by relevance Sort by date |
| Related Blogs: | American Cancer Society :: Information and Resources for Cancer ... - http://www.cancer.org/ Metastatic Breast Cancer - News and Views - http://advancedbc.org/blog/ OncoEd Professional Education Home Page - http://www.oncoed.com/ American College of Radiology - http://www.acr.org/ Wisconsin Breast Cancer Coalition - http://www.standupandspeakout.org/ | |
| 9 Dec 2009 32nd Annual San Antonio Breast Cancer Symposium (SABCS): Read clinically focused news coverage of key developments from the meeting. Medscape Hematology-Oncology Headlines - http://www.medscape.com/oncology - References [ More results from Medscape Hematology-Oncology Headlines ] |
| 10 Dec 2009 Denosumab Significantly Reduced Risk Of Developing Multiple Skeletal Related Events By 23 Percent Versus Zometa(R) In Advanced Breast Cancer Patients Amgen (NAS. Drugs.com - Clinical Trials - http://www.drugs.com/clinical_trials.html [ More results from Drugs.com - Clinical Trials ] |
| 14 Dec 2009 by meganfulton 27th), met up in Texas for the 32nd Annual San Antonio Breast Cancer Conference last week. The event is the largest of its kind in the world! With 10000 attendees, the duo was able to meet and strengthen relationships with oncologists, ... Imerman Angels Blog - http://imermanangels.org/blog/ |
| 15 Dec 2009 These results were presented at the 2009 San Antonio Breast Cancer Symposium (SABCS). Avastin is a targeted therapy that blocks a protein known as VEGF. VEGF plays a key role in the development of new blood vessels. ... Breast Cancer News - http://ww5.komen.org/News.aspx [ More results from Breast Cancer News ] |
| 16 hours ago by By Martha Rosenberg But the women on bisphosphonates, in the paper presented at the Annual San Antonio Breast Cancer Symposium, were also more likely to get noninvasive breast cancer called ductal carcinoma in situ (DCIS). ... Epoch Times | All headlines - http://www.theepochtimes.com/ |
| 9 Dec 2009 Pfizer is planning to present new findings on several targeted oncologics at a major breast cancer conference this week, offering a peek into the company's ongoing work in cancer personalization. At the San Antonio Breast Cancer Symposium being held Dec. 9–13, Pfizer will present new clinical trial data on neratinib, an investigational pan-ErbB inhibitor in patients with HER2-positive breast cancer, as well as data on the marketed oncologic Sutent (sunitinib malate) in ... Pharmacogenomics Reporter from GenomeWeb News - http://www.genomeweb.com/newsletter/4 |
| 10 Dec 2009 "Women with breast cancer who are postmenopausal or overweight seem to be most susceptible to the effects of alcohol," she tells WebMD. The findings were presented at the San Antonio Breast Cancer Symposium. ... WebMD Health News Center - The latest breaking... - http://www.webmd.com/ - References [ More results from WebMD Health News Center - The latest breaking... ] |
| 8 Dec 2009 by Business Wire LOS ANGELES--(BUSINESS WIRE)-- The Group Room cancer talk show, produced by Vital Options International, will take place live from the 32nd Annual CTRC-AACR San Antonio Breast Canc. Your Story - http://www.your-story.org/ [ More results from Your Story ] |
| 14 Dec 2009 by admin Breast cancer continues to be a dynamic field of research, and the CTRC-AACR San Antonio Breast Cancer Symposium, now in its 32nd year, is the premier destination to present new data on emerging therapies. See the original post: ... Cure Breast Cancer Blog - http://www.pinklightsofhope.com/ |
| 12 Dec 2009 by Musa Mayer If it's December, you'll find me hanging out with 8400 scientists, doctors, researchers, pharma folks and advocates at the San Antonio Breast Cancer Symposium, the largest annual scientific meeting devoted exclusively to breast cancer ... Metastatic Breast Cancer - News and Views - http://advancedbc.org/blog/ |
Stay up to date on these results:
| Google Home - About Google Blog Search Beta - Information for Blog Authors |